Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
4.45
Nov 02 • 3:59 PM ET Dollar change+0.15 Percentage change(3.49%)
Aftermarket Close
4.45
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
503.11M
Enterprise Value
1.33B
Income
-511.06M
Sales
2.10B
Book/sh
3.40
Cash/sh
1.23
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
4200
IPO
Jun 05, 2015
P/E
-
Forward P/E
12.50
PEG
0.17
P/S
0.24
P/B
1.31
P/C
3.63
P/FCF
20.67
EV/EBITDA
15.16
EV/Sales
0.64
Quick Ratio
1.24
Current Ratio
1.24
Debt/Eq
2.53
LT Debt/Eq
2.53
Option/Short
Yes / Yes
EPS (ttm)
-4.57
EPS next Y
0.36
EPS next Q
0.06
EPS this Y
89.21%
EPS next Y
108.99%
EPS next 5Y
74.81%
EPS past 3/5Y
-194.21% -5.21%
Sales past 3/5Y
11.54% 15.20%
EPS Y/Y TTM
-184.71%
Sales Y/Y TTM
-4.50%
EPS Q/Q
42.84%
Sales Q/Q
46.86%
Insider Own
9.42%
Insider Trans
-0.61%
Inst Own
89.77%
Inst Trans
-1.65%
ROA
-22.78%
ROE
-78.95%
ROIC
-37.35%
Gross Margin
11.89%
Oper. Margin
-1.33%
Profit Margin
-24.37%
SMA20
-0.17%
SMA50
6.21%
SMA200
14.93%
Trades
Shs Outstand
112.68M
Shs Float
102.41M
52W High
6.89 -35.41%
52W Low
2.10 112.41%
Volatility
5.95% 6.77%
ATR (14)
0.27
RSI (14)
53.12
Beta
1.03
Rel Volume
0.57
Avg Volume
2.52M
Volume
1,430,316
Perf Week
-1.77%
Perf Month
28.61%
Perf Quarter
43.09%
Perf Half Y
11.53%
Perf YTD
11.25%
Perf Year
-33.28%
Perf 3Y
-81.47%
Perf 5Y
-84.84%
Perf 10Y
-77.69%
Prev Close
4.30
Price
4.45
Change %
3.49%
Consensus
Strong Buy
Avg. Price Target
$5.75
Implied Upside
+29.2%
Analysts13incl. previous ratings
Rating Distribution11 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Aug 11, 2026Upgrade
C logoCCitigroup
Neutral → Buy$6+34.8%
Jul 23, 2026Downgrade
C logoCCitigroup
Buy → Sell$6.75+51.7%
Jun 30, 2026Downgrade
TFC logoTTruist
Buy → Hold$7+57.3%
Feb 25, 2026Downgrade
KEY logoKKeyBanc Capital Markets
Overweight → Sector Weight
Nov 13, 2025Upgrade
SStephens
Equal-Weight → Overweight$7+57.3%
Nov 13, 2025Initiated
BMO logoBBMO Capital Markets
Outperform$7+57.3%
Jan 10, 2025Initiated
NNeedham
Buy$15+237.1%
Dec 03, 2024Reiterated
BBTIG Research
Buy$36 → $29+551.7%
Nov 08, 2024Downgrade
SStephens
Overweight → Equal-Weight$38 → $16+259.6%
Oct 11, 2024Initiated
KEY logoKKeyBanc Capital Markets
Overweight$35+686.5%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McCarthy Daniel JosephPRESIDENTAug 26 '26Sale5.0065,892329,460655,133Aug 28 04:17 PM
Daniel McCarthyOfficerAug 26 '26Proposed Sale4.9765,892327,476Aug 26 05:42 PM
Springstubb Brendan BDirectorNov 18 '25Buy3.8210,00038,19958,821Nov 19 04:23 PM
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.
Co-FounderMr. Seth Barrie Blackley
PresidentMr. Dan McCarthy
Chief Legal OfficerMr. Jonathan David Weinberg J.D.
Chief Strategy OfficerMr. John Paul Johnson
Chief Financial OfficerMr. Mario Marques Ramos